Ashley Modell

Ashley Modell is a Senior Scientist at Pfizer since April 2022, bringing a robust background in chemistry and scientific research. Prior roles include two postdoctoral associate positions at Harvard Medical School and the Broad Institute of MIT and Harvard from February 2020 to February 2022, where key contributions included developing strategic partnerships and serving as Project Manager for a DARPA grant. Ashley's doctoral research at New York University focused on fragment-based approaches to targeting protein interactions, culminating in 7+ publications, 12 grants, and 1 patent. Earlier experience includes a research assistantship at Memorial Sloan-Kettering Cancer Center, investigating RUNX1 post-translational modifications in leukemia cell lines. Ashley holds a Ph.D. in Chemistry from New York University and a B.A. in Chemistry from Boston University.